REPLIMUNE GROUP INC. - COMMON STOCK
8.9800
30-5月-25 13:45:00
15 分の遅延
株式
-0.3900
-4.16%
本日の幅
8.6100 - 9.3500
ISIN
N/A
ソース
NASDAQ
-
Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference
28 12 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
08 11 2023 06:10:00 提供 Nasdaq GlobeNewswire
-
Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update
07 11 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
03 11 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 9 2023 13:01:00 提供 Nasdaq GlobeNewswire
-
Replimune Announces Appointment of Emily Hill as Chief Financial Officer
19 9 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
Replimune Reports Fiscal First Quarter 2024 Financial Results and Provides Corporate Update
03 8 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
Replimune to Present at Two Upcoming Investor Conferences
01 8 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
Replimune Announces Sander Slootweg will Depart from its Board of Directors
20 7 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
06 6 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Replimune Appoints Veleka R. Peeples-Dyer to its Board of Directors
05 6 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
Replimune to Present at the Jefferies Global Healthcare Conference
01 6 2023 13:01:00 提供 Nasdaq GlobeNewswire
-
Replimune to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
25 5 2023 14:00:00 提供 Nasdaq GlobeNewswire
-
18 5 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
Replimune to Participate in the Piper Sandler Spring Biopharma Symposium
09 5 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
Replimune to Present at Two Upcoming Investor Conferences
08 3 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
Replimune Reports Fiscal Third Quarter Financial Results and Provides Corporate Update
09 2 2023 05:00:01 提供 Nasdaq GlobeNewswire
-
Replimune to Present at the Virtual SVB Securities Global Biopharma Conference
07 2 2023 05:00:02 提供 Nasdaq GlobeNewswire